Penumbra, Inc Research and Development Expense
Penumbra, Inc (PEN) reported Research and Development Expense of $21.54 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2023-08-01
- Penumbra, Inc research and development expense for the quarter ending 2023-06-30 was $21.54M, a 10.11% increase year-over-year.
- Penumbra, Inc research and development expense for the quarter ending 2023-03-31 was $19.99M, a 2.81% decline year-over-year.
- Penumbra, Inc research and development expense for the quarter ending 2022-09-30 was $21.32M, a 27.41% increase year-over-year.
- Penumbra, Inc research and development expense for the quarter ending 2022-06-30 was $19.56M, a 10.27% increase year-over-year.
- Penumbra, Inc research and development expense for fiscal 2018 was $36.16M, a 14.23% increase from fiscal 2017.
- Penumbra, Inc research and development expense for fiscal 2017 was $31.66M, a 32.61% increase from fiscal 2016.
- Penumbra, Inc research and development expense for fiscal 2016 was $23.88M, a 32.44% increase from fiscal 2015.
- Penumbra, Inc research and development expense for fiscal 2015 was $18.03M, a 15.74% increase from fiscal 2014.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $21.54M 10-Q · filed 2023-08-01 | $41.52M 10-Q · filed 2023-08-01 | ||
| 2023-03-31 | $19.99M 10-Q · filed 2023-05-02 | |||
| 2022-09-30 | $21.32M 10-Q · filed 2022-11-03 | $40.88M derived: sum of 2 quarters · filed 2023-08-01 | $61.44M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $19.56M 10-Q · filed 2023-08-01 | $40.12M 10-Q · filed 2023-08-01 | ||
| 2022-03-31 | $20.56M 10-Q · filed 2023-05-02 | |||
| 2021-09-30 | $16.73M 10-Q · filed 2022-11-03 | $34.47M derived: sum of 2 quarters · filed 2022-11-03 | $52.55M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $17.74M 10-Q · filed 2022-08-05 | $35.81M 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $18.08M 10-Q · filed 2022-05-03 | |||
| 2020-09-30 | $34.92M 10-Q · filed 2021-11-03 | $57.65M derived: sum of 2 quarters · filed 2021-11-03 | $70.59M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $22.73M 10-Q · filed 2021-08-09 | $35.67M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $12.95M 10-Q · filed 2021-05-04 | |||
| 2019-09-30 | $13.73M 10-Q · filed 2020-11-02 | $27.20M derived: sum of 2 quarters · filed 2020-11-02 | $38.86M 10-Q · filed 2020-11-02 | $49.73M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | $13.46M 10-Q · filed 2020-08-03 | $25.13M 10-Q · filed 2020-08-03 | $36.00M derived: sum of 3 quarters · filed 2020-08-03 | $45.09M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | $11.67M 10-Q · filed 2020-05-07 | $22.53M derived: sum of 2 quarters · filed 2020-05-07 | $31.63M derived: sum of 3 quarters · filed 2020-05-07 | $39.82M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $10.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $19.96M derived: sum of 2 quarters · filed 2019-11-07 | $28.15M derived: sum of 3 quarters · filed 2019-11-07 | $36.16M 10-K · filed 2019-02-26 |
| 2018-09-30 | $9.09M 10-Q · filed 2019-11-07 | $17.29M derived: sum of 2 quarters · filed 2019-11-07 | $25.30M 10-Q · filed 2019-11-07 | $33.70M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $8.19M 10-Q · filed 2019-08-06 | $16.21M 10-Q · filed 2019-08-06 | $24.61M derived: sum of 3 quarters · filed 2019-08-06 | $32.74M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $8.01M 10-Q · filed 2019-05-07 | $16.41M derived: sum of 2 quarters · filed 2019-05-07 | $24.55M derived: sum of 3 quarters · filed 2019-05-07 | $32.64M derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-31 | $8.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $16.53M derived: sum of 2 quarters · filed 2019-02-26 | $24.63M derived: sum of 3 quarters · filed 2019-02-26 | $31.66M 10-K · filed 2019-02-26 |
| 2017-09-30 | $8.13M 10-Q · filed 2017-11-07 | $16.23M derived: sum of 2 quarters · filed 2018-08-07 | $23.26M 10-Q · filed 2017-11-07 | $29.37M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $8.09M 10-Q · filed 2018-08-07 | $15.13M 10-Q · filed 2018-08-07 | $21.24M derived: sum of 3 quarters · filed 2019-02-26 | $27.74M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $7.03M 10-Q · filed 2018-05-08 | $13.15M derived: sum of 2 quarters · filed 2019-02-26 | $19.64M derived: sum of 3 quarters · filed 2019-02-26 | $25.91M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $12.61M derived: sum of 2 quarters · filed 2019-02-26 | $18.87M derived: sum of 3 quarters · filed 2019-02-26 | $23.88M 10-K · filed 2019-02-26 |
| 2016-09-30 | $6.50M 10-Q · filed 2017-11-07 | $12.76M derived: sum of 2 quarters · filed 2017-11-07 | $17.76M 10-Q · filed 2017-11-07 | $23.25M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $6.26M 10-Q · filed 2017-08-08 | $11.27M 10-Q · filed 2017-08-08 | $16.75M derived: sum of 3 quarters · filed 2018-02-27 | $21.31M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $5.00M 10-Q · filed 2017-05-09 | $10.48M derived: sum of 2 quarters · filed 2018-02-27 | $15.04M derived: sum of 3 quarters · filed 2018-02-27 | $19.84M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $5.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $10.04M derived: sum of 2 quarters · filed 2018-02-27 | $14.84M derived: sum of 3 quarters · filed 2018-02-27 | $18.03M 10-K · filed 2018-02-27 |
| 2015-09-30 | $4.56M 10-Q · filed 2016-11-03 | $9.35M derived: sum of 2 quarters · filed 2016-11-03 | $12.54M 10-Q · filed 2016-11-03 | $16.68M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $4.79M 10-Q · filed 2016-08-09 | $7.98M 10-Q · filed 2016-08-09 | $12.12M derived: sum of 3 quarters · filed 2017-02-28 | $16.02M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $3.19M 10-Q · filed 2016-05-09 | $7.33M derived: sum of 2 quarters · filed 2017-02-28 | $11.23M derived: sum of 3 quarters · filed 2017-02-28 | |
| 2014-12-31 | $4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $8.04M derived: sum of 2 quarters · filed 2017-02-28 | $15.57M 10-K · filed 2017-02-28 | |
| 2014-09-30 | $3.90M 10-Q · filed 2015-11-12 | $11.44M 10-Q · filed 2015-11-12 | ||
| 2013-12-31 | $14.08M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |